Showing results (411-420 of 466) with videos related to
Sort By:
Pageof 47
International Journal of Radiation Oncology, Biology, Physics|March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasJing Zeng, Alfred P See, Jillian Phallen, et al.Journal of Neurosurgery. Spine|August 1, 2015
Prognostic factors associated with pain palliation after spine stereotactic body radiation therapyVarun Puvanesarajah, Sheng-Fu Larry Lo, Nafi Aygun, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic BiopsyShanshan Jiang, Charles G Eberhart, Michael Lim, et al.JACC. Clinical Electrophysiology|April 25, 2025
Impact of Mitral Regurgitation on Outcomes of Catheter Ablation for AF With Left Ventricular Systolic DysfunctionLouise Segan, Sandeep Prabhu, Shane Nanayakkara, et al.Cancer Cell|April 28, 2023
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulatorsAleksandar Obradovic, Casey Ager, Mikko Turunen, et al.Oncotarget|June 18, 2020
Efficacy of osimertinib against EGFRvIII+ glioblastomaGustavo Chagoya, Shawn G Kwatra, Cory W Nanni, et al.Journal of the American Medical Informatics Association : JAMIA|December 13, 2016
Synergistic drug combinations from electronic health records and gene expressionYen S Low, Aaron C Daugherty, Elizabeth A Schroeder, et al.Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.Journal for Immunotherapy of Cancer|May 19, 2016
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial gliomaMira A Patel, Jennifer E Kim, Debebe Theodros, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and VaccinationChristopher M Jackson, Christina M Kochel, Christopher J Nirschl, et al.Pageof 47